TOSCO - Solutions/Service Company
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

TOSCO: Stabilizing Supply Chain of Pharmaceutical Raw Materials

Atsushi TSUMORI, CEO, TOSCOAtsushi TSUMORI, CEO
While any manufacturing operation depends on the seamless supply of raw materials, pharmaceutical manufacturers, in particular, have to burn the midnight oil to stabilize the supply chain network for procuring raw materials. Along with a growing demand for cost-effective services, quality, and on-time supply of raw materials, pharmaceutical manufacturers are often bottlenecked due to strict regulations. Taking note of these concerns, the Japanese company Tosco facilitates a steady supply of key starting materials (KSMs), intermediates, active pharmaceutical ingredients (APIs), and other raw materials for its pharmaceutical clients. Along with several stipulated requirements, including cost, quality, timely supplies of raw materials, and regulatory approvals, the company also fulfills many unstated requirements such as good packaging, transportation, and others to ensure a hassle-free experience for its pharmaceutical clients.

In order to stabilize the supply chain of pharmaceutical raw materials, the company opened its manufacturing plant in India since the country is quickly garnering recognition as the procurement and development hub for pharmaceutical raw materials. At its Vizag plant in Andhra Pradesh, India, skilled chemists are constantly working in the R&D department for process development and optimization to maintain optimum quality while remaining cost-efficient. Notably, the Indian plant also enables the company to use raw materials and reactions for which permissions are not granted by authorities in many countries, despite their high efficiency. Another advantage is Tosco’s ability to stably procure materials from China in cooperation with Shanghai Tosco. This helps to stabilize the supply chain for its clients as well as its own manufacturing plant in India.

Tosco does not take a one-size-fits-all approach and understands the clients’ desired schedule, price, quality and other requirements to avoid irresponsible initiation of work.
If the consulting process is successful, Tosco starts the R&D study and then nurtures the project consistently through scale-up to industrial and mass production, thereby eliminating clients’ need to rope-in multiple partners for each development stage.

“Our consistent support eliminates the need to find a separate development partner for each development stage, and reduces unnecessary time, cost, and the risk of information leakage,” states Atsushi Tsumori, CEO of Tosco. Above all, the company boasts a proficient team with a wide range of technical experience to respond appropriately to clients’ requirements in each development stage.

Moreover, while many other players outsource raw materials from third parties and supplies to their clients, Tosco developed the technology at its Indian manufacturing site, produced those products in-house, and stabilized the supplies, instilling a tremendous amount of confidence in its clients. An in-house manufacturing ability also gave Tosco the advantage of stabilizing prices amidst the dynamic price fluctuations of input materials globally. Besides, the company maintains stocks of many significant products at its manufacturing site to meet the immediate demands of customers.
  • Our consistent support eliminates the need to find a separate development partner for each development stage, and reduces unnecessary time, cost, and the risk of information leakage


Since 1980, the company has been supplying a variety of KSMs and intermediates to pharmaceutical companies in Japan and its manufacturing plant in India has already been audited several times by major Japanese pharmaceutical companies. The company strives for continual improvements to meet various stringent safety, quality, and regulatory requirements of its clients across borders. To this end, Tosco has placed additional production equipment to meet customers’ specific needs, such as high vacuum distillations, handling of catalysts, metal reactions, and others. Along with setting up cleanrooms for intermediates and APIs, the company has also improved its manufacturing facilities to better control the passage of pests and rodents, and insects. Also, to ensure optimum quality, Tosco regularly updates its quality management systems to meet the existing as well as future needs of industry and regulators.
Share this Article:
Top 10 Cmos In Apac - 2022

Company
TOSCO

Headquarters
Tokyo, Japan

Management
Atsushi TSUMORI, CEO

Description
Tosco facilitates a steady supply of key starting materials (KSMs), intermediates, active pharmaceutical ingredients (APIs), and other raw materials for its pharmaceutical clients. Along with several stipulated requirements, including cost, quality, timely supplies of raw materials, and regulatory approvals, the company also fulfills many unstated requirements such as good packaging, transportation, and others to ensure a hassle-free experience for its pharmaceutical clients. Further, in order to stabilize the supply chain of pharmaceutical raw materials, the company opened its manufacturing plant in India since the country is quickly garnering recognition as the procurement and development hub for pharmaceutical raw materials.

TOSCO